<?xml version="1.0" encoding="UTF-8"?>
<p>The cardiovascular community faces unprecedented challenges during the coronavirus disease 2019 (COVID-19) pandemic. For heart transplant (HT) clinicians, the global pandemic has unique implications for patients, including those on the waiting list and transplant recipients. These populations are at increased risk for both acquisition of COVID-19 infection and progression to severe disease given multiple healthcare contacts, underlying health conditions, and immunosuppression; targeted prevention and treatment strategies are needed.</p>
